Endothelial gap junction (EGJ)

Endothelial cell connexin-based gap junctions are specialized transmembrane channels that facilitate direct cytoplasmic communication between adjacent endothelial cells and between endothelial and smooth muscle cells (myoendothelial junctions) (Isakson et al., 2001, PMID: 11334414). These junctions are primarily composed of three connexin isoforms: Connexin 37 (Cx37), Connexin 40 (Cx40), and Connexin 43 (Cx43), which hexamerize to form connexons (Figueroa et al., 2004, PMID: 15155265). They play a vital role in vascular physiology by coordinating vasomotor responses, such as the conduction of hyperpolarization and the synchronization of calcium signaling across the vessel wall (Chaytor et al., 1998, PMID: 9714502). In pathological states like atherosclerosis and hypertension, the expression and function of these junctions are often altered, contributing to endothelial dysfunction and impaired blood flow regulation (Schmidt et al., 2008, PMID: 18258928). Therapeutic strategies targeting these junctions include the use of connexin-mimetic peptides like Gap26 and Gap27, which are designed to inhibit excessive hemichannel activity or modulate gap junctional coupling to treat cardiovascular and inflammatory conditions (Evans et al., 2002, PMID: 12107557). Small molecule modulators such as danegaptide have also been explored for their potential to enhance coupling and protect against ischemia-reperfusion injury (Haugan et al., 2005, PMID: 16123472).

Other names

Endothelial cell connexin-based gap junctionVascular gap junctionMyoendothelial gap junctionConnexin-based intercellular channel

Modulation of gap junctional intercellular communication (GJIC) and hemichannel activity through competitive inhibition by mimetic peptides or stabilization of connexin protein interactions by small molecules.